ECCMID

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	The website's WordPress theme uses this cookie. It allows the website owner to implement or change the website's content in real-time.
PHPSESSID	session	This cookie is native to PHP applications. The cookie stores and identifies a user's unique session ID to manage user sessions on the website. The cookie is a session cookie and will be deleted when all the browser windows are closed.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_pk_id.*	1 year 27 days	Matamo set this cookie to store a unique user ID.
_pk_ses.*	30 minutes	Matomo set this cookie to store a unique session ID for gathering information on how the users use the website.

Multiple Dose Pharmacokinetics of an Immediate-Release Tablet Formulation of F901318 in Healthy Male and Female Subjects

In Vitro Susceptibility Testing of the Novel Orotomide Antifungal Agent F901318 against Australian Scedosporium and Lomentospora Pathogens

An Open Label Study in Healthy Volunteers to Evaluate the Potential for Cytochrome P450 3A4 Inhibition by F901318 using Oral Midazolam as a Probe

Assessment of the duration of infusion on the tolerability and repeat dose pharmacokinetics of F901318 in healthy volunteers

The Novel Orotomide F901318 Demonstrates Potent In vitro Antifungal Activity Against Lomentospora and Scedosporium Species

Activity of F901318 against azole-resistant and difficult-to-treat Aspergillus species

Olorofim for a case of severe disseminated Lomentospora prolificans infection

Antifungal susceptibility profiles of olorofim [formerly F901318), and currently available systemic antifungals against mould and yeast phases of Talaromyces marneffei

A case of Lomentospora prolificans (Lo Pro) treated with the novel antifungal olorofim

Successful use of the novel antifungal olorofim in the treatment of disseminated coccioidomycosis